The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea

被引:144
作者
Hurley, BW
Nguyen, CC
机构
[1] Mayo Clin Scottsdale, Div Hosp Internal Med, Scottsdale, AZ 85259 USA
[2] Mayo Clin Scottsdale, Div Gastroenterol & Hepatol, Scottsdale, AZ 85259 USA
关键词
D O I
10.1001/archinte.162.19.2177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pseudomembranous (entero)colitis is primarily caused by Clostridium difficile infection. The most common predisposing factor is prior use of antibiotics, including vancomycin and metronidazole, which themselves are therapy for C difficile colitis. Other risk factors have also been described. The presence of C difficile in the gastrointestinal tract leads to a spectrum of manifestations from the asymptomatic carrier state to fulminant colitis. Successful treatment of C difficile colitis requires prompt treatment with appropriate antibiotics, withdrawal of the suspected predisposing antibiotics, and, in rare cases, total colectomy. Preventive measures of adequate infection control and judicious use of antibiotics are necessary means in attempting to control the spread of C difficile infection. Attempts at making an effective human vaccine are currently under way.
引用
收藏
页码:2177 / 2184
页数:8
相关论文
共 32 条
[1]   Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene [J].
Alonso, R ;
Muñoz, C ;
Gros, S ;
Garcia de Viedma, D ;
Peláez, T ;
Bouza, E .
JOURNAL OF HOSPITAL INFECTION, 1999, 41 (02) :145-149
[2]  
[Anonymous], 1893, Bull Johns Hopkins Hosp
[3]  
BARTLETT JG, 1998, SLEISENGER FORDTRANS, V2, P1633
[4]   Pseudomembranous colitis - An update [J].
Brar, HS ;
Surawicz, CM .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2000, 14 (01) :51-56
[5]  
Chetham ST, 1996, GASTROENTEROLOGY, V110, pA882
[6]   ACQUISITION OF CLOSTRIDIUM-DIFFICILE BY HOSPITALIZED-PATIENTS - EVIDENCE FOR COLONIZED NEW ADMISSIONS AS A SOURCE OF INFECTION [J].
CLABOTS, CR ;
JOHNSON, S ;
OLSON, MM ;
PETERSON, LR ;
GERDING, DN .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (03) :561-567
[7]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - RESULTS FROM 3-YEAR FOLLOW-UP [J].
CLEMENS, JD ;
SACK, DA ;
HARRIS, JR ;
VANLOON, F ;
CHAKRABORTY, J ;
AHMED, F ;
RAO, MR ;
KHAN, MR ;
YUNUS, M ;
HUDA, N ;
STANTON, BF ;
KAY, BA ;
WALTER, S ;
EECKELS, R ;
SVENNERHOLM, AM ;
HOLMGREN, J .
LANCET, 1990, 335 (8684) :270-273
[8]  
Fekety R, 1997, AM J GASTROENTEROL, V92, P739
[9]  
FERNIE DS, 1982, DEV BIOLOGICALS, V53, P325
[10]  
HAFITZ S, 1974, THESIS U LEEDS LEEDS